![Gilead's $3B Truvada will face generics a year early. Can Descovy still win over its patients? | Fierce Pharma Gilead's $3B Truvada will face generics a year early. Can Descovy still win over its patients? | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1557414560/truvada.jpg?VersionId=HRmBaz_VBQE1Fq1Tzvg00gT.5aWTnKsM)
Gilead's $3B Truvada will face generics a year early. Can Descovy still win over its patients? | Fierce Pharma
![Andrew Leavitt on Twitter: "This is what Teva's generic PrEP looks like in Ireland. Light green is the new baby blue! https://t.co/YM3XpjLbTf" / Twitter Andrew Leavitt on Twitter: "This is what Teva's generic PrEP looks like in Ireland. Light green is the new baby blue! https://t.co/YM3XpjLbTf" / Twitter](https://pbs.twimg.com/media/DQNlcieX0AE3oGI.jpg)
Andrew Leavitt on Twitter: "This is what Teva's generic PrEP looks like in Ireland. Light green is the new baby blue! https://t.co/YM3XpjLbTf" / Twitter
Ben Ryan: Journalist - THE AGE OF GENERIC TRUVADA HAS BEGUN Teva Pharmaceuticals has launched the first generic version of Truvada for use as PrEP and HIV treatment. It will have a
![First Truvada Anti-HIV Drug Generic Approved By FDA, But Will Not Be Immediately Available - Life4me+ First Truvada Anti-HIV Drug Generic Approved By FDA, But Will Not Be Immediately Available - Life4me+](https://s3.eu-central-1.amazonaws.com/life4me.plus/uploads/photos/1497106779_593c095b06c65.jpeg)
First Truvada Anti-HIV Drug Generic Approved By FDA, But Will Not Be Immediately Available - Life4me+
PrEP Updates Newsletter Editors: Volume 2, Issue 1, November 2020 Katherine Frasca, MD Infectious Diseases Group Practice
![Andrew Leavitt on Twitter: "This is what Teva's generic PrEP looks like in Ireland. Light green is the new baby blue! https://t.co/YM3XpjLbTf" / Twitter Andrew Leavitt on Twitter: "This is what Teva's generic PrEP looks like in Ireland. Light green is the new baby blue! https://t.co/YM3XpjLbTf" / Twitter](https://pbs.twimg.com/media/DQNlcinWAAE6Fr4.jpg)